Noom vs Zealthy
Zealthy has an open FDA warning letter dated September 9, 2025. Noom has none. No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Noom / Zealthy
Noom
5.8/10
Zealthy
5.6/10
Neither Noom nor Zealthy pays us. Links to them earn nothing. Scores: Noom 5.8, Zealthy 5.6. How we are paid
What the record shows
- 01
Zealthy has an open FDA warning letter dated September 9, 2025. Noom has none.
- 02
Neither names the pharmacy that compounds its medication.
- 03
No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.
- 04
Only Noom lists a price for brand-name tirzepatide pen. Only Zealthy lists a price for compounded tirzepatide injection.
- 05
Zealthy lists all 50 states. Noom publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Noom
Zealthy
$179/mo
$2,148 a year
$286/mo
medication only, membership extra; not compared
$351/mo
medication only, membership extra; not compared
$349/mo
$4,188 a year
Read off each seller’s own pages. Noom: October 30, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Noom
5.8/10- No FDA warning letter on record
- Sells brand-name tirzepatide pen, which Zealthy does not price
- Names no compounding pharmacy
- Publishes no state list
The case for Zealthy
5.6/10- Sells compounded tirzepatide injection, which Noom does not price
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Lowest price covers the medication only, with a separate membership on top
Scores
Noom 5.8 · Zealthy 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Noom vs Zealthy: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Luvo Health7.9
From $179/mo
Visit site - Gala8.5
From $179/mo
Visit site - HealthRX8.2
From $165/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks